Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
The American Journal of Surgical Pathology|April 24, 2010
Granulomatous reaction to pneumocystis jirovecii: clinicopathologic review of 20 casesPaul H Hartel, Konstantin Shilo, Mary Klassen-Fischer, et al.
Oncotarget|March 18, 2015
Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stabilityCatherine A Powell, Mohd W Nasser, Helong Zhao, et al.
Cancer Research|December 3, 2008
SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cellsHyo-Sung Jeon, Tatiana Dracheva, Sei-Hoon Yang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2007
Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior seriesPaul H Hartel, Julie C Fanburg-Smith, Aletta A Frazier, et al.
Diagnostic Pathology|March 16, 2012
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimensSean Kirby, Anjali Satoskar, Sergey Brodsky, et al.
Breast Cancer (Dove Medical Press)|June 22, 2026
Induced Electric Fields Inhibit Breast Cancer Growth and Metastasis and Modulate the Immune Tumor MicroenvironmentManish Charan, Travis H Jones, Dinesh K Ahirwar, et al.
JCO Precision Oncology|June 4, 2025
Hypoxic Gene Expression Signature as a Predictor of Recurrence and Mortality in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation TherapyNicholas J Eustace, Nikhil T Sebastian, Amy Webb, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 24, 2009
Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysisIrem H Ozbudak, Konstantin Shilo, Fabio Tavora, et al.
International Journal of Cancer|March 16, 2019
Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic miceWenrui Duan, Li Gao, Arjun Kalvala, et al.
Cell Death & Disease|June 5, 2021
Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lungWalter Z Wang, Konstantin Shilo, Joseph M Amann, et al.
Pageof 9